LYEL
Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lyell Immunopharma, Inc. shareholder equity for the quarter ending December 31, 2025 were 248.2M, a 35.17% decrease year-over-year.
- Lyell Immunopharma, Inc. shareholder equity for 2025 were 248.2M, a 35.17% decrease from 2024.
- Lyell Immunopharma, Inc. shareholder equity for 2024 were 382.8M, a 41.55% decrease from 2023.
- Lyell Immunopharma, Inc. shareholder equity for 2023 were 655.0M, a 21.40% decrease from 2022.
- Lyell Immunopharma, Inc. shareholder equity for 2022 were 833.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Lyell Immunopharma, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $248 |
| 2024 | $383 |
| 2023 | $655 |
| 2022 | $833 |
| 2021 | $930 |
| 2020 | $-293 |
| Lyell Immunopharma, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $248 |
| 2024-12-31 | $383 |
| 2023-12-31 | $655 |
| 2022-12-31 | $833 |
| 2021-12-31 | $930 |
| 2020-12-31 | $-293 |
Lyell Immunopharma, Inc. Shareholder Equity — FAQ
Lyell Immunopharma, Inc. (LYEL) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LYEL's shareholder equity history?
The chart and table above show Lyell Immunopharma, Inc.'s shareholder equity by year and by quarter, including the growth rate.